Adverse effects such as tachycardia, infections, headaches, dizziness, nausea, vomiting, diarrhea, and dyspepsia, as well as contraindications such as a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia type 2, hypersensitivity, severe gastrointestinal diseases, renal impairment, and pregnancy have been noted
California Privacy Notice California residents may have rights under the California Consumer Privacy Act and other California law, subject to statutory applicability and exceptions
GLP-1 agonists should not directly impair sleep, but if you are taking doses late in the day, residual GI discomfort may disrupt rest
However, ongoing monitoring depends on patient-initiated check-ins rather than mandatory follow-up labs
Q1 2027: Lilly plans to submit its BLA to the FDA